Countries and Regions Covered by OGPS Offices
The Office of Global Policy and Strategy (OGPS) promotes and protects Americans by ensuring global considerations are fully integrated into FDA's activities around the world.
OGPS OFFICE | COUNTRY/ECONOMY/REGION | FDA CONTACT |
---|---|---|
Office of Global Operations - HQ | AFGHANISTAN | US-FDA-OGO@fda.hhs.gov |
Europe | ALBANIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | ALGERIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | AMERICAN SAMOA | US-FDA-OGO@fda.hhs.gov |
Europe | ANDORRA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | ANGOLA | US-FDA-OGO@fda.hhs.gov |
Latin America | ANGUILLA | US-FDA-LAO@fda.hhs.gov |
Latin America | ANTIGUA & BARBUDA | US-FDA-LAO@fda.hhs.gov |
Latin America | ARGENTINA | US-FDA-LAO@fda.hhs.gov |
Europe | ARMENIA | US-FDA-EUR@fda.hhs.gov |
Latin America | ARUBA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | AUSTRALIA | US-FDA-OGO@fda.hhs.gov |
Europe | AUSTRIA | US-FDA-EUR@fda.hhs.gov |
Europe | AZERBAIJAN | US-FDA-EUR@fda.hhs.gov |
Latin America | BAHAMAS | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | BAHRAIN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | BANGLADESH | US-FDA-OGO@fda.hhs.gov |
Latin America | BARBADOS | US-FDA-LAO@fda.hhs.gov |
Europe | BELARUS | US-FDA-EUR@fda.hhs.gov |
Europe | BELGIUM | US-FDA-EUR@fda.hhs.gov |
Latin America | BELIZE | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | BENIN | US-FDA-OGO@fda.hhs.gov |
Latin America | BERMUDA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | BHUTAN | US-FDA-OGO@fda.hhs.gov |
Latin America | BOLIVIA | US-FDA-LAO@fda.hhs.gov |
Europe | BOSNIA-HERZEGOVINA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | BOTSWANA | US-FDA-OGO@fda.hhs.gov |
Latin America | BRAZIL | US-FDA-LAO@fda.hhs.gov |
Europe | BRITISH INDIAN OCEAN TERRITORY | US-FDA-EUR@fda.hhs.gov |
Latin America | BRITISH VIRGIN ISLANDS | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | BRUNEI DARUSSALAM | US-FDA-OGO@fda.hhs.gov |
Europe | BULGARIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | BURKINA FASO | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | BURMA (MYANMAR) | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | BURUNDI | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | CAMBODIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | CAMEROON | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | CANADA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | CAPE VERDE | US-FDA-OGO@fda.hhs.gov |
Latin America | CAYMAN ISLANDS | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | CENTRAL AFRICAN REPUBLIC | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | CHAD | US-FDA-OGO@fda.hhs.gov |
Latin America | CHILE | US-FDA-LAO@fda.hhs.gov |
China | CHINA | US-FDA-CNO@fda.hhs.gov |
Office of Global Operations - HQ | CHRISTMAS ISLANDS (INDIAN OCN) | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | COCOS ISLANDS | US-FDA-OGO@fda.hhs.gov |
Latin America | COLOMBIA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | COMOROS | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | COOK ISLANDS | US-FDA-OGO@fda.hhs.gov |
Latin America | COSTA RICA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | COTE D’IVOIRE (IVORY COAST) | US-FDA-OGO@fda.hhs.gov |
Europe | CROATIA | US-FDA-EUR@fda.hhs.gov |
Latin America | CUBA | US-FDA-LAO@fda.hhs.gov |
Europe | CYPRUS | US-FDA-EUR@fda.hhs.gov |
Europe | CZECH REPUBLIC | US-FDA-EUR@fda.hhs.gov |
Europe | DENMARK | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | DJIBOUTI | US-FDA-OGO@fda.hhs.gov |
Latin America | DOMINICA | US-FDA-LAO@fda.hhs.gov |
Latin America | DOMINICAN REPUBLIC | US-FDA-LAO@fda.hhs.gov |
Latin America | ECUADOR | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | EGYPT | US-FDA-OGO@fda.hhs.gov |
Latin America | EL SALVADOR | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | EQUATORIAL GUINEA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | ERITREA | US-FDA-OGO@fda.hhs.gov |
Europe | ESTONIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | ESWATINI | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | ETHIOPIA | US-FDA-OGO@fda.hhs.gov |
Latin America | FALKLAND ISLANDS | US-FDA-LAO@fda.hhs.gov |
Europe | FAROE ISLANDS | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | FIJI | US-FDA-OGO@fda.hhs.gov |
Europe | FINLAND | US-FDA-EUR@fda.hhs.gov |
Europe | FRANCE | US-FDA-EUR@fda.hhs.gov |
Latin America | FRENCH GUIANA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | FRENCH POLYNESIA | US-FDA-OGO@fda.hhs.gov |
Europe | FRENCH SOUTHERN ANTARCTIC | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | GABON | US-FDA-OGO@fda.hhs.gov |
Europe | GEORGIA | US-FDA-EUR@fda.hhs.gov |
Europe | GERMANY | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | GHANA | US-FDA-OGO@fda.hhs.gov |
Europe | GIBRALTAR | US-FDA-EUR@fda.hhs.gov |
Europe | GREECE | US-FDA-EUR@fda.hhs.gov |
Europe | GREENLAND | US-FDA-EUR@fda.hhs.gov |
Latin America | GRENADA | US-FDA-LAO@fda.hhs.gov |
Latin America | GUADELOUPE | US-FDA-LAO@fda.hhs.gov |
Latin America | GUATEMALA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | GUINEA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | GUINEA BISSAU | US-FDA-OGO@fda.hhs.gov |
Latin America | GUYANA | US-FDA-LAO@fda.hhs.gov |
Latin America | HAITI | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | HEARD & MCDONALD ISLANDS | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | HONG KONG | US-FDA-OGO@fda.hhs.gov |
Latin America | HONDURAS | US-FDA-LAO@fda.hhs.gov |
Europe | HUNGARY | US-FDA-EUR@fda.hhs.gov |
Europe | ICELAND | US-FDA-EUR@fda.hhs.gov |
India | INDIA | US-FDA-INO@fda.hhs.gov |
Office of Global Operations - HQ | INDONESIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | IRAN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | IRAQ | US-FDA-OGO@fda.hhs.gov |
Europe | IRELAND | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | ISRAEL | US-FDA-OGO@fda.hhs.gov |
Europe | ITALY | US-FDA-EUR@fda.hhs.gov |
Latin America | JAMAICA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | JAPAN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQs | JORDAN | US-FDA-OGO@fda.hhs.gov |
Europe | KAZAKHSTAN | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | KENYA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | KIRIBATI | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | KOREA, DEMOCRATIC PEOPLES REPUBLIC | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | KOREA, REPUBLIC OF (SOUTH) | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | KUWAIT | US-FDA-OGO@fda.hhs.gov |
Europe | KYRGYZSTAN | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | LAOS | US-FDA-OGO@fda.hhs.gov |
Europe | LATVIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | LEBANON | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | LESOTHO | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | LIBERIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | LIBYA | US-FDA-OGO@fda.hhs.gov |
Europe | LIECHTENSTEIN | US-FDA-EUR@fda.hhs.gov |
Europe | LITHUANIA | US-FDA-EUR@fda.hhs.gov |
Europe | LUXEMBOURG | US-FDA-EUR@fda.hhs.gov |
Europe | MACEDONIA (The Former Yugoslavian Republic of Macedonia) | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | MADAGASCAR | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MALAWI | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MALAYSIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MALDIVES | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MALI | US-FDA-OGO@fda.hhs.gov |
Europe | MALTA & GOZO | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | MARIANA ISLANDS | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MARSHALL ISLANDS | US-FDA-OGO@fda.hhs.gov |
Latin America | MARTINIQUE | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | MAURITANIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MAURITIUS | US-FDA-OGO@fda.hhs.gov |
Latin America | MEXICO | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | MICRONESIA, FEDERATED STATE OF | US-FDA-OGO@fda.hhs.gov |
Europe | MOLDOVA | US-FDA-OGO@fda.hhs.gov |
Europe | MONACO | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | MONGOLIA | US-FDA-OGO@fda.hhs.gov |
Europe | MONTENEGRO | US-FDA-EUR@fda.hhs.gov |
Latin America | MONTSERRAT | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | MOROCCO | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | MOZAMBIQUE | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NAMIBIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NAURU | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NEPAL | US-FDA-OGO@fda.hhs.gov |
Europe | NETHERLANDS | US-FDA-EUR@fda.hhs.gov |
Latin America | NETHERLANDS ANTILLES | US-FDA-LAO@fda.hhs.gov |
Europe | NEW CALEDONIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | NEW ZEALAND | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NIGER | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NIGERIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NIUE | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | NORFOLK ISLAND | US-FDA-OGO@fda.hhs.gov |
Europe | NORWAY | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | OMAN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | PAKISTAN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | PALAU | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | PALESTINIAN AUTHORITY/WEST BANK | US-FDA-OGO@fda.hhs.gov |
Latin America | PANAMA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | PAPUA NEW GUINEA | US-FDA-OGO@fda.hhs.gov |
Latin America | PARAGUAY | US-FDA-LAO@fda.hhs.gov |
Latin America | PERU | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | PHILIPPINES | US-FDA-OGO@fda.hhs.gov |
Europe | PITCAIRN ISLAND | US-FDA-EUR@fda.hhs.gov |
Europe | POLAND | US-FDA-EUR@fda.hhs.gov |
Europe | PORTUGAL | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | QATAR | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | REUNION | US-FDA-OGO@fda.hhs.gov |
Europe | ROMANIA | US-FDA-EUR@fda.hhs.gov |
Europe | RUSSIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | RWANDA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SAINT HELENA | US-FDA-OGO@fda.hhs.gov |
Latin America | SAINT LUCIA | US-FDA-LAO@fda.hhs.gov |
Europe | SAINT PIERRE & MIQUELON | US-FDA-EUR@fda.hhs.gov |
Europe | SAN MARINO | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | SAO TOME AND PRINCIPE | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SAUDI ARABIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SENEGAL | US-FDA-OGO@fda.hhs.gov |
Europe | SERBIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | SEYCHELLES | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SIERRA LEONE | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SINGAPORE | US-FDA-OGO@fda.hhs.gov |
Europe | SLOVAKIA | US-FDA-EUR@fda.hhs.gov |
Europe | SLOVENIA | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | SOLOMON ISLANDS | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SOMALIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SOUTH AFRICA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SOUTH SUDAN | US-FDA-OGO@fda.hhs.gov |
Europe | SPAIN | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | SRI LANKA | US-FDA-OGO@fda.hhs.gov |
Latin America | St. CHRISTOPHER (KITTS) - NEVIS | US-FDA-LAO@fda.hhs.gov |
Latin America | ST. VINCENT & THE GRENADINES | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | SYRIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | SUDAN | US-FDA-OGO@fda.hhs.gov |
Latin America | SURINAME | US-FDA-LAO@fda.hhs.gov |
Europe | SVALBARD & JAN MAYEN ISLANDS | US-FDA-EUR@fda.hhs.gov |
Europe | SWEDEN | US-FDA-EUR@fda.hhs.gov |
Europe | SWITZERLAND | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | SYRIA | US-FDA-OGO@fda.hhs.gov |
Europe | TAJIKISTAN | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | TAIWAN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TANZANIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | THAILAND | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TIMOR LESTE (EAST TIMOR) | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TOGO | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TOKELAU ISLANDS | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TONGA | US-FDA-OGO@fda.hhs.gov |
Latin America | TRINIDAD & TOBAGO | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | TUNISIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | TURKEY | US-FDA-OGO@fda.hhs.gov |
Europe | TURKMENISTAN | US-FDA-EUR@fda.hhs.gov |
Latin America | TURKS & CAICOS ISLAND | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | TUVALU | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | UGANDA | US-FDA-OGO@fda.hhs.gov |
Europe | UKRAINE | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | UNITED ARAB EMIRATES | US-FDA-OGO@fda.hhs.gov |
Europe | UNITED KINGDOM | US-FDA-EUR@fda.hhs.gov |
Latin America | URUGUAY | US-FDA-LAO@fda.hhs.gov |
Europe | UZBEKISTAN | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | VANUATU | US-FDA-OGO@fda.hhs.gov |
Europe | VATICAN CITY STATE | US-FDA-EUR@fda.hhs.gov |
Latin America | VENEZUELA | US-FDA-LAO@fda.hhs.gov |
Office of Global Operations - HQ | VIETNAM | US-FDA-OGO@fda.hhs.gov |
Europe | WALLIS & FUTUNA ISLANDS | US-FDA-EUR@fda.hhs.gov |
Office of Global Operations - HQ | WESTERN SAMOA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | YEMEN | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | ZAMBIA | US-FDA-OGO@fda.hhs.gov |
Office of Global Operations - HQ | ZIMBABWE | US-FDA-OGO@fda.hhs.gov |